AUBH2013 SLIDES

Kian Ang Memorial Lecture: Building Bridges Across Nations with Clinical Trials: Borje Andersson, MD, PhD

New Agents in ALL: Jorge Cortes, MD

DEBATE: Alternative Donor for Aplastic Anemia?

YES: Seiji Kojima, MD, PhD

NO: William Hwang, MD

DEBATE: Cure of APML without Chemotherapy

YES: Auro Viswabandya, MD

NO: Jiong Hu, MD

DEBATE: High Risk MDS Upfront Transplant

YES: Tapan Kadia, MD 

NO:Suporn Chancharunee, MD

DEBATE: Hypomethylating agents for induction for elderly     
                    AML

YES: David Ritchie, MD, PhD

NO: Subhash Varma, MD

DEBATE: Imatinib as frontline treatment for CML                                   

YES: Jorge Cortes, MD

NO: Hemant Malhotra, MD

DEBATE: Standard induction in AML

YES: Tapan Kadia, MD

NO: JianXiang Wang, MD

DEBATE: Therapy for adult Thalassemia Hypertransfusion and chelation

YES:  Noppadol  Siritanaratkul, MD    

NO:  Usanarat Anurathapan, MD    

DEBATE: Upfront Transplant in Ph positive ALL

YES:Jorge Cortes, MD

NO: Pankaj Malhotra, MD

Targeted Therapy in Hodgkin's Lymphoma: David Ritchie, MD, PhD

Therapy of Choice for CML: Tapan Kadia, MD

Treatment Breakthroughs in CLL: Jane Huang, MD

Updates on Treatment of chronic ITP: Raymond Wong, MD

Advances in Stem Cell Transplant: Past! Present! Future? Borje S. Andersson, MD, Ph.D.                                                                                                                            

Autologous vs. Allogeneic Stem Cell Transplant for Multiple Myeloma--Uday Popat, MD

DEBATE: What is the best approach in patients who achieve CR with Brentuximab Vedotin after failing Autologous Stem Cell Transplant?

Immediate Allo-SCT-
                Borje   Andersson, MD                  

Delayed Allo-SCT-David Ritchie, MD

DEBATE: Haploidentical vs. Matched Unrelated Donor Transplant

Haplo-Uday Popat, MD

MUD-Seji Kojima, MD PhD

DEBATE: Haploidentical vs. Cord Blood Transplant

Haplo: Ying-Jun Chang, MD

Cord:William Hwang, MD